My interest in cancer research started with my first research experience as an undergraduate student at Nankai University in China. I then completed my M.S. in tumor biology at Georgetown University in 2015. During my Ph.D. at Michigan State University, I was trained as a pharmacologist, and worked on investigating the role of inflammation in cancer and developing new drugs for prevention or treatment of cancers. I joined Dr. Ming-Ru Wu’s lab as a postdoctoral research fellow in May 2020. I am excited to expand my skillsets from pharmacological approaches to genetic strategies, and combat cancer in another way. My ultimate goal is to develop new therapies for cancer treatment and provide cancer patients a better outcome and quality of life.